Table 2.
IEDB B-cell assay record counts of selection in Figure 1.
| Method/technique | Total | Positive | Negative |
|---|---|---|---|
| Ab-dependent Phagocytosis/opsonization |
162 | 120 | 42 |
| Antibody-dependent cellular cytotoxicity | 42 | 34 | 8 |
| Complement-dependent cytotoxicity | 63 | 34 | 29 |
| Enhancement/activation of antigen activity | 21 | 10 | 11 |
| Exacerbation of disease after treatment | 185 | 93 | 92 |
| Hypersensitivity | 20 | 14 | 6 |
| Ig-mediated histamine release | 8 | 7 | 1 |
| Induction of tolerance | 66 | 51 | 15 |
| Inhibition of Ab biological activity | 17 | 12 | 5 |
| Neutralization/inhibition of antigen activity | 1995 | 1337 | 658 |
| Protection after challenge | 858 | 499 | 359 |
| Protection from fertility | 79 | 50 | 29 |
| Reduction of disease after treatment | 125 | 96 | 29 |
| Survival after challenge | 325 | 211 | 114 |
| All of the above methods/techniques | 3966 | 2568 | 1398 |